Clinical Trials
12 trialsNCT06001658 2025-12-03
Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
NCT02412670 2023-07-10
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT01088815 2019-04-26
Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00226590 2017-03-23
Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT01469598 2015-12-29
Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer
Samsung Medical Center
Phase 2 Completed
NCT01019382 2014-12-04
A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer
University Hospitals, Leicester
Phase 2 Completed
NCT00589667 2014-04-02
A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00401570 2013-01-30
A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer
AbbVie
Phase 2 Completed
NCT00735904 2013-01-03
Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer
Pfizer
Phase 2 Completed
NCT00192842 2010-09-22
Gemcitabine With Curcumin for Pancreatic Cancer
Rambam Health Care Campus
Phase 2 Completed
NCT00905983 2009-05-21
Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients
Hospital Arnau de Vilanova
Phase 2 Unknown
NCT00191763 2007-11-06
Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer
Eli Lilly and Company
Phase 2 Completed